
ASN Kidney Translation Series: JASN Late-Breaking Clinical Trials
Notas del episodio
This episode of ASN Kidney Translation Podcast, we review 2 late-breaking clinical trials: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. The authors discuss efficacy, safety, and implications for kidney practice
Todos los episodios de Journal of the American Society of Nephrology (JASN)